STOCK TITAN

Collegium to Participate in Upcoming Investor Conferences

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences

Collegium Pharmaceutical (Nasdaq: COLL) has announced its upcoming participation in three major healthcare investor conferences in March 2025. The company's management will engage in investor meetings at the Leerink Partners 2025 Global Healthcare Conference on March 11, the Jefferies Biotech on the Beach Summit on March 12, and the Barclays 27th Annual Global Healthcare Conference on March 13.

Loading...
Loading translation...
Argus Session date unavailable
-1.41% session move Open Argus
Details

News Market Reaction – COLL

The recorded move for COLL in the trading session of this news was -1.41%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

STOUGHTON, Mass., March 04, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that management will participate in investor meetings at the following investor conferences:

Leerink Partners 2025 Global Healthcare Conference
Tuesday, March 11, 2025

Jefferies Biotech on the Beach Summit
Wednesday, March 12, 2025

Barclays 27th Annual Global Healthcare Conference
Thursday, March 13, 2025

About Collegium Pharmaceutical, Inc.
Collegium is building a leading, diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The Company has a leading portfolio of responsible pain management medications and recently acquired Jornay PM®, a treatment for ADHD, establishing a presence in neuropsychiatry. Collegium’s strategy includes growing its commercial portfolio, with Jornay PM as the lead growth driver, and deploying capital in a disciplined manner. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company’s website at www.collegiumpharma.com.

Investor Contacts:
Ian Karp
Head of Investor Relations
ir@collegiumpharma.com

Danielle Jesse
Director, Investor Relations
ir@collegiumpharma.com

Media Contact:
Cheryl Wheeler
Head of Corporate Communications
communications@collegiumpharma.com


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Which investor conferences will Collegium Pharmaceutical (COLL) attend in March 2025?

Collegium will attend three conferences: Leerink Partners Global Healthcare Conference (March 11), Jefferies Biotech on the Beach Summit (March 12), and Barclays Global Healthcare Conference (March 13).

When is Collegium Pharmaceutical (COLL) presenting at the Leerink Partners 2025 Conference?

Collegium management will participate in investor meetings at the Leerink Partners Global Healthcare Conference on Tuesday, March 11, 2025.

What is the schedule for COLL's participation in the Barclays Healthcare Conference 2025?

Collegium will participate in the Barclays 27th Annual Global Healthcare Conference on Thursday, March 13, 2025.

Is Collegium (COLL) participating in the Jefferies Biotech on the Beach Summit 2025?

Yes, Collegium management will participate in investor meetings at the Jefferies Biotech on the Beach Summit on Wednesday, March 12, 2025.

Keep reading